Literature DB >> 29724803

Pharmacology, Part 2: Introduction to Pharmacokinetics.

Geoffrey M Currie1.   

Abstract

Pharmacology principles provide a key understanding that underpins the clinical and research roles of nuclear medicine practitioners. This article is the second in a series of articles that aims to enhance the understanding of pharmacologic principles relevant to nuclear medicine. This article will build on the introductory concepts, terminology, and principles of pharmacodynamics explored in the first article in the series. Specifically, this article will focus on the basic principles associated with pharmacokinetics. Article 3 will outline pharmacology relevant to pharmaceutical interventions and adjunctive medications used in general nuclear medicine; article 4, pharmacology relevant to pharmaceutical interventions and adjunctive medications used in nuclear cardiology; article 5, pharmacology relevant to contrast media associated with CT and MRI; and article 6, drugs in the emergency cart.
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Keywords:  drug metabolism; drug safety; medication; pharmacokinetics; pharmacology

Mesh:

Substances:

Year:  2018        PMID: 29724803     DOI: 10.2967/jnmt.117.199638

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  8 in total

Review 1.  Simulation Models for Prediction of Bioavailability of Medicinal Drugs-the Interface Between Experiment and Computation.

Authors:  Mahmoud E Soliman; Adeniyi T Adewumi; Oluwole B Akawa; Temitayo I Subair; Felix O Okunlola; Oluwayimika E Akinsuku; Shahzeb Khan
Journal:  AAPS PharmSciTech       Date:  2022-03-15       Impact factor: 3.246

2.  Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives.

Authors:  Ayu Masyita; Reka Mustika Sari; Ayun Dwi Astuti; Budiman Yasir; Nur Rahma Rumata; Talha Bin Emran; Firzan Nainu; Jesus Simal-Gandara
Journal:  Food Chem X       Date:  2022-01-19

3.  A Model Perspective Explanation of the Long-Term Sustainability of a Fully Human BCMA-Targeting CAR (CT103A) T-Cell Immunotherapy.

Authors:  Wei Mu; Xiaolu Long; Haodong Cai; Caixia Chen; Guang Hu; Yaoyao Lou; Shugang Xing; Di Wang; Jue Wang; Min Xiao; Kun Wang; Zhongyi Sun; Chunrui Li; Jianfeng Zhou; Liting Chen
Journal:  Front Pharmacol       Date:  2022-02-02       Impact factor: 5.810

4.  Preparation of a camptothecin analog FLQY2 self-micelle solid dispersion with improved solubility and bioavailability.

Authors:  Yi Wang; Wenchao Wang; Endian Yu; Wenya Zhuang; Xuanrong Sun; Hong Wang; Qingyong Li
Journal:  J Nanobiotechnology       Date:  2022-09-05       Impact factor: 9.429

Review 5.  A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer.

Authors:  Hilla Mills; Ronald Acquah; Nova Tang; Luke Cheung; Susanne Klenk; Ronald Glassen; Magali Pirson; Alain Albert; Duong Trinh Hoang; Thang Nguyen Van
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-09       Impact factor: 2.650

Review 6.  Current trends in drug metabolism and pharmacokinetics.

Authors:  Yuhua Li; Qiang Meng; Mengbi Yang; Dongyang Liu; Xiangyu Hou; Lan Tang; Xin Wang; Yuanfeng Lyu; Xiaoyan Chen; Kexin Liu; Ai-Ming Yu; Zhong Zuo; Huichang Bi
Journal:  Acta Pharm Sin B       Date:  2019-10-18       Impact factor: 11.413

7.  Novel Naproxen Salts with Increased Skin Permeability.

Authors:  Ewelina Świątek; Paula Ossowicz-Rupniewska; Ewa Janus; Anna Nowak; Peter Sobolewski; Wiktoria Duchnik; Łukasz Kucharski; Adam Klimowicz
Journal:  Pharmaceutics       Date:  2021-12-07       Impact factor: 6.321

8.  A comparative study between CT, MRI, and intraoral US for the evaluation of the depth of invasion in early stage (T1/T2) tongue squamous cell carcinoma.

Authors:  Masaki Takamura; Taichi Kobayashi; Yutaka Nikkuni; Kouji Katsura; Manabu Yamazaki; Satoshi Maruyama; Jun-Ichi Tanuma; Takafumi Hayashi
Journal:  Oral Radiol       Date:  2021-05-10       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.